MedPath

TIAZAC XC

TIAZAC XC

Approved
DIN Number

02256770

Drug Class

Human

Market Date

Aug 13, 2004

Company
HC

bausch health, canada inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02256770
AIG Number0115863009
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
C08DB01 DILTIAZEM
Product Specifications
Dosage FormTablet (Extended-Release)
Route of AdministrationOral
AHFS Classification24:28.92
Health Canada Classification

ACTIVE INGREDIENTS (1)

DILTIAZEM HYDROCHLORIDEActive
Strength: 360 MG
Monograph: DILTIAZEM HYDROCHLORIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.